Summary
The pharmacological properties of the endothelial 5-hydroxytryptamine (5-HT) receptors involved in relaxation of vascular smooth muscle were determined in rings of pig coronary artery contracted with 10 nmol/1 of the thromboxane A2 receptor agonist 9,11-dideoxy-11α,9α-epoxy-methano-prostaglandin F2α (U 46619).
(1) In the presence of 10 μmol/l ketanserin, relaxation was obtained with: 5-HT (apparent pD2 value 7.00), 5-carboxamidotryptamine (5-CONH2-T; 6.42), 5-aminotryptamine (5-NH2-T; 5.96), 5-methoxytryptamine (5-OCH3-T; 5.92), tryptamine, 7-trifluoromethyl-4(4-methyl-1-piperazinyl)-pyrrolo(1,2-a)quinoxaline maleate (CGS 12066 A) and 5-methoxy-3(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole succinate (RU 24969). The maximum relaxation obtainable with the agonists was about 40–60% of the U 46619-induced contraction and the concentration-response curves for 5-HT, 5-NH2-T and 5-OCH3-T were bell-shaped. The endothelium-dependence of this effect (i. e. the failure to relax the artery in endothelium-denuded preparations) was demonstrated for 5-HT, 5-CONH2-T, RU 24969, CGS 12066A and tryptamine.
(2) 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), 4-hydroxytryptamine, quipazine and yohimbine were ineffective in decreasing the tension of arteries with or without endothelium. Ipsapirone elicited full relaxation of U 46619-induced contraction, but this effect was not endothelium-dependent.
(3) Metitepine (0.03-1 μmol/l), 6-chloro-2-(1-piperazinyl)pyrazine (MK 212; 10 μmol/l), methysergide (1 gmol/l) and cyanopindolol (0.1 μmol/l) antagonized the relaxing effect of 5-HT in a non-surmountable manner, whereas metergoline (0.1 μmol/l), quipazine (10 μmol/l), yohimbine (1 μmol/l), propranolol (1 μmol/l) and (3α-tropanyl)-1H-indole-3-carboxylic acid ester (ICS 205-930; 0.1 μmol/l) did not. However, spiroxatrine (0.1 μmol/l) and mesulergine (10 μmol/l) enhanced the 5-HT-induced relaxation. The endothelium-dependent relaxation induced by 5-CONH2-T was also inhibited by metitepine 1 gmol/l.
(4) The 5-HT-induced relaxation was probably mediated by release of an endothelium-derived relaxing factor (EDRF). Gossypol, an inhibitor of EDRF, virtually abolished the 5-HT-induced relaxation while indometacin, an inhibitor of cyclooxygenase and accordingly of PGI2 formation, did not.
In conclusion, the failure of ketanserin and ICS 205–930 to counteract the relaxant effect of 5-HT receptor agonists excludes the involvement of 5-HT2 and 5-HT3 receptors, respectively, in the endothelium-dependent relaxation of the porcine coronary artery. The rather high potency of 5-CONH2-T and the ability of certain 5-HT receptor antagonists, such as metitepine, methysergide and cyanopindolol, to counteract the effect of 5-HT are compatible with a “5-HT1” character of the endothelial receptor. However, on the basis of the present data, no final classification, in particular with respect to the known “5-HT1” receptor subtypes, is possible. Classification is also hampered by the bell-shaped character of the concentration-response curves for 5-HT receptor agonists and by their property to produce only partial relaxation.
Similar content being viewed by others
References
Alheid U, Dudel C, Förstermann U (1987) Selective inhibition by gossypol of endothelium-dependent relaxation augments relaxations to glyceryltrinitrate in rabbit coeliac artery. Br J Pharmacol 92:237–240
Benedict CR, Mathew B, Rex KA, Cartwright J, Sordahl LA (1986) Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 58:58–67
Blier P, De Montigny C (1983) Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS. Neuropharmacology 22:495–499
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Chu A, Cobb FR (1987) Vasoactive effects of serotonin on proximal coronary arteries in awake dogs. Circ Res 61, Suppl II:81–87
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627–630
Cohen RA (1985) Serotonergic prejunctional inhibition of canine coronary adrenergic nerves. J Pharmacol Exp Ther 235:76–80
Cohen ML, Fuller RW, Wiley KS (1981) Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther 218:421–425
Cohen RA, Shepherd JT, Vanhoutte PM (1983) 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 245:H 1077-H 1080
Cohen RA, Zitnay KM, Weisbrod RM (1987) Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo. Circ Res 61:829–833
Connor HE, Feniuk W, Humphrey PPA, Perren MJ (1986) 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br J Pharmacol 87:417–426
Da Prada M, Picotti GB (1979) Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: Monoamine distribution between platelets and plasma. Br J Pharmacol 65:653–662
Dompert WU, Glaser T, Traber J (1985) [3H]-TVXQ 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn-Schmiedeberg's Arch Pharmacol 328: 467–470
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-HT autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7
Feniuk W, Humphrey PPA, Watts AD (1983) 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol 96:71–78
Feniuk W, Humphrey PPA, Perren MJ, Watts AD (1985) A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697–704
Frenken M, Kaumann AJ (1985) Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog. Naunyn-Schmiedeberg's Arch Pharmacol 328: 301–303
Garland CJ (1985) Endothelial cells and the electrical and mechanical responses of the rabbit coronary artery to 5-hydroxytryptamine. J Pharmacol Exp Ther 233:158–162
Göthert M, Schlicker E (1987) Classification of serotonin receptors. J Cardiovasc Pharmacol 10 Suppl 3: S3-S7
Göthert M, Kollecker P, Rohm N, Zerkowski HR (1986) Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 332:317–323
Gulati N, Mathison R, Huggel H, Regoli D, Beny JL (1987) Effects of neurokinins on the isolated pig coronary artery. Eur J Pharmacol 137:149–154
Gutterman DD, Rusch NJ, Hermsmeyer K, Dole WP (1986) Differential reactivity to 5-hydroxytryptamine in canine coronary arteries. Blood Vessels 23:165–172
Hartmann A, Saeed M, Bing RJ (1987) Release of endothelium-derived relaxing factor from freshly harvested porcine endothelial cells. Circ Res 61:548–554
Hirafuji M, Akiyama Y, Ogura Y (1987) Receptor-mediated stimulation of aortic prostacyclin release by 5-hydroxytryptamine. Eur J Pharmacol 143:259–265
Houston DS, Shepherd JT, Vanhoutte PM (1985) Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets. Am J Physiol 248:H 389-H 395
Houston DS, Vanhoutte PM (1988) Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J Pharmacol Exp Ther 244: 1–10
Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]-5-HT, [3H]-8-OH-DPAT, (−)125I-iodocyanopindolol, [3H]-mesulergine and [3H]-ketanserin. Eur J Pharmacol 118:13–23
Kokkas B, Boeynaems JM (1988) Release of prostacyclin from the dog saphenous vein by 5-hydroxytryptamine. Eur J Pharmacol 147:473–476
Leff P, Martin GR (1988) The classification of 5-hydroxytryptamine receptors. Med Res Rev 8:187–202
Leff P, Martin GR, Morse JM (1987) Differential classification of vascular smooth muscle and endothelial cell 5-HT receptor by use of tryptamine analogues. Br J Pharmacol 91: 321–331
Lüscher TF, Rubanyi GM, Aaarhus LL, Edoute Y, Vanhoutte PM (1986) Serotonin reduces coronary flow in the isolated heart of the spontaneously hypertensive rat. J Hypertension 4 (Suppl 5): S 148-S 150
Luscher TF, Raij L, Vanhoutte PM (1987) Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9:157–163
Markstein R, Hoyer D, Engel G (1986) 5-HT1A receptors mediate stimulation of adenylate cyclase in rat hippocampus. NaunynSchmiedeberg's Arch Pharmacol 333:335–341
Martin GR, Leff P, Cambridge D, Barrett VJ (1987) Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn-Schmiedeberg's Arch Pharmacol 336:365–373
Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151–153
Molderings GJ, Fink K, Schlicker E, Göthert M (1987) Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn-Schmiedeberg's Arch Pharmacol 336:245–250
Molderings GJ, Engel G, Göthert M (1988) Pharmacological characterization of an endothelial serotonin receptor mediating relaxation of the pig coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 337 Suppl: R103
Molderings GJ, Göthert M, Fink K, Roth E, Schlicker E (1989) Inhibition of noradrenaline release in the pig coronary artery via a novel serotonin receptor. Eur J Pharmacol 164:213–222
Neale RF, Fallon SL, Boyar WC, Wasley JWF, Martin LL, Stone GA, Glaeser BS, Sinton CM, Williams M (1987) Biochemical and pharmacological characterization of CGS 12066 B, a selective serotonin-1 B agonist. Eur J Pharmacol 136:1–9
Nelson DL, Taylor EW (1986) Spiroxatrine: a selective serotonin1A receptor antagonist. Eur J Pharmacol 124:207–208
Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11:45–60
Saxena PR, Verdouw PD (1985) 5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arterio-venous anastomoses. Br J Pharmacol 84:533–544
Schoeffter P, Waeber C, Palacios JM, Hoyer D (1988) The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schmiedeberg's Arch Pharmacol 337:602–608
Shimokawa H, Lam JYT, Chesebro JH, Bowie EJW, Vanhoutte PM (1987) Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation 76:898–905
Uma S, Tuncer M, Kayaalp SO (1987) The subtype of serotonin (5-HT) receptors in the rat pulmonary artery. Arch Int Pharmacodyn Ther 288:248–255
Van Nueten JM, Janssen PA, De Ridder W, Vanhoutte PM (1982) Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41468). Eur J Pharmacol 77:281–287
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 337: 595–601
Young AR, McKenzie ET, Seylaz J, Verrecchia C (1986) Receptors involved in the 5-hydroxytryptamine-induced contraction of isolated cerebral arteries. Acta Physiol Scand 127 Suppl 552:54–57
Author information
Authors and Affiliations
Additional information
Send offprint requests to M. Gothert at the above address
Rights and permissions
About this article
Cite this article
Molderings, G.J., Engel, G., Roth, E. et al. Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 340, 300–308 (1989). https://doi.org/10.1007/BF00168514
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168514